BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//pretalx//sciencenext.org//ifos2026//SUGEPV
BEGIN:VTIMEZONE
TZID:EET
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20061029T000000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20071028T050000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20141026T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20151108T050000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=11;UNTIL=20151108T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20160907T010000
RRULE:FREQ=YEARLY;BYDAY=1WE;BYMONTH=9
TZNAME:+03
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20060326T000000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20070325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20100328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20110328T040000
RRULE:FREQ=YEARLY;BYDAY=4MO;BYMONTH=3;UNTIL=20110328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20120325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20130331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20140331T040000
RRULE:FREQ=YEARLY;BYDAY=5MO;BYMONTH=3;UNTIL=20140331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20150329T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20160327T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:pretalx-ifos2026-CJ8LFP@sciencenext.org
DTSTART;TZID=EET:20260911T083000
DTEND;TZID=EET:20260911T090000
DESCRIPTION:1 - Description:
<
p style="text-align: start\; margin-left: 0px!important\;">Total laryngect
omy remains the gold standard surgical treatment for advanced-stage laryng
eal carcinoma\, especially in cases where organ-preserving protocols have
failed or are contraindicated. This instructional session will provide a s
tepwise overview of the total laryngectomy procedure. Participants will re
view surgical anatomy\, incision planning\, organ mobilization\, pharyngea
l reconstruction\, and tracheostoma creation. The session also addresses k
ey decision-making in salvage versus primary laryngectomy\, complications
such as pharyngocutaneous fistula. Real case examples\, surgical videos\,
and evidence-based strategies will enhance the learning experience.2 - Outcome Objectives:
· \; \; \; \; \;
\; Explain the indications and contraindications for total laryngectomy
· \; \; \; \;&nb
sp\; \; Demonstrate anatomical and technical steps of the total laryng
ectomy procedure
· \;
\; \; \; \; \; Recognize common intraoperative and postope
rative complications
· \;&
nbsp\; \; \; \; \; Implement effective postoperative care<
/p>
· \; \; \; \;&
nbsp\; \; Interpret imaging and histopathology to guide surgical plann
ing
3 - Structure of the Sessi
on:
· \; \; \;&nb
sp\; \; \; Introduction and Indications
· \; \; \; \; \; \; Preoperative
Planning and Counseling
·&nbs
p\; \; \; \; \; \; Step-by-Step Surgical Technique wit
h Key Tips
· \; \;&nbs
p\; \; \; \; Complications and Management
4 - Background (Key References):
1. \; \; \; \; Türk Kulak Buru
n Boğaz ve Baş Boyun Cerrahisi Vakfı\, 10. İlkbahar toplantısı\, Pre
sented on “İleri Evre Larenks Kanseri”\, sharing clinical insights an
d surgical experience about Total Laryngectomy’s role in organ preservat
ion era
2. \; \; \;
\; Yılmaz\, Y. Z.\, Uğurlar\, M.\, Yılmaz\, B. B.\, Gülmez\, Z. D
.\, Özdoğan\, H. A.\, Ataş\, A.\, &\; Batıoğlu-Karaaltın\, A. (20
23). The comparison of narrow band imaging\, white light laryngoscopy and
videolaryngostroboscopy in the evaluation of benign vocal fold lesions.&nb
sp\;Journal of Voice\, \;37(2)\, 275-281.
3. \; \; \; \; Yilmaz YZ\
, et al. "Surgical perspectives in head and neck oncology." Turkish Archiv
es of Otorhinolaryngology. 2022.
4. \; \; \; \; Yılmaz\, Yetkin Zeki\, et al. "COVID-19
in patients with total laryngectomy." \;Praxis of Otorhinolaryngol
ogy/Kulak Burun Boğaz Uygulamaları \;10.2 (2022).
5. \; \; \; \; Yılmaz\, Yet
kin Zeki\, et al. "Diagnostic and Prognostic Value of M30 and M65 in Laryn
geal Squamous Cell Carcinoma." \;Journal of Academic Research in M
edicine \;11.3 (2021).
6. \; \; \; \; YILMAZ\, Yetkin Zeki\, et al. "Primary Nas
opharyngeal Neuroendocrine Carcinoma: An Extremely Rare Clinical Entity."&
nbsp\;EURAS JOURNAL OF HEALTH: 155.
7. \; \; \; \; Sari\, E.\, Tokat\, T.\, Tarb
an\, O.\, Dag\, H.\, Yilmaz\, Y. Z.\, &\; Yener\, H. M. (2020). Compari
son of tumor infiltrating lymphocyte density with histopathological parame
ters and effect on prognosis in head and neck squamous cell cancers. \
;Şişli Etfal Hastanesi Tip Bülteni\, \;54(4)\, 43
8-443.
DTSTAMP:20260618T223109Z
LOCATION:Head & Neck Surgery 3
SUMMARY:Step by Step: Total Laryngectomy - Ozlem Unsal\, Yetkin Zeki YILMAZ
URL:https://sciencenext.org/ifos2026/talk/CJ8LFP/
END:VEVENT
END:VCALENDAR